The Association between COVID-19 Infection and both rs34224237IL-6 and rs1800871 IL-10 Gene Polymorphisms
DOI:
https://doi.org/10.32792/utq/utjsci/v12i1.1305Abstract
Investigate the polymorphism of the IL-6 and IL-10 genes in COVID-19 patients was the goal of this study. Fifty COVID-19 patients and 50 samples as control used in this study on 7/12/2023. The results recorded that a significantly relation (P= 0.03) of rs34224237 (AAAAAAAAA SNP) was detected in the studied samples (COVID-19) and control, that variation of A nucleotide in position 22726806. While, the results of this study showed a high significantly relationship (P= 0.0007) of rs1800871 (A>G) in position 206773289. In conclusion, This study showed the polymorphism of IL-10 (rs1800871, A>G SNP) was a highly significantly associated with COVID-19 infection, which could be employed as a diagnostic marker for COVID-19 infections.
Received:2024-09-22
Revised: 2024-10-31
Accepted:2024-12-10
References
C.-C. Lai, T.-P. Shih, W.-C. Ko, H.-J. Tang, and P.-R. Hsueh, “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges,” International Journal of Antimicrobial Agents, vol. 55, no. 3, p. 105924, Feb. 2020.
J. F.-W. Chan et al., “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster,” The Lancet, vol. 395, no. 10223, Jan. 2020.
Y. Jamilloux et al., “Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions,” Autoimmunity Reviews, vol. 19, no. 7, p. 102567, Jul. 2020.
R. de C. C. M. de Brito, N. Lucena-Silva, L. C. Torres, C. F. Luna, J. de B. Correia, and G. A. P. da Silva, “The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia,” BMC Pulmonary Medicine, vol. 16, no. 1, Dec. 2016.
S. Roy and P. Ghosh, “Factors affecting COVID-19 infected and death rates inform lockdown-related policymaking,” PLOS ONE, vol. 15, no. 10, p. e0241165.
I. Jančić et al., “-174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis,” Rheumatology International, vol. 33, no. 6, pp. 1481–1486, Dec. 2012.
M. K. Vakil et al., “Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll‐like receptors dictates pathophysiology of COVID‐19 disease,” Journal of Medical Virology, vol. 94, no. 9, pp. 4088–4096, May 2022.
K. W. Moore, R. de Waal Malefyt, R. L. Coffman, and A.O’Garra,“ Interleukin-10 and the interleukin-10 Receptors,” Annual Review of Immunology, vol. 19, no. 1,pp. 683–765, Apr. 2001.
H. Li et al., “SARS-CoV-2 and viral sepsis: observations and hypotheses,” The Lancet, vol. 395, no. 10235, Apr. 2020.
D. Fiorentino, A. Zlotnik, T. R. Mosmann, M. A. Howard, and A. O’Garra, “IL-10 inhibits cytokine production by activated macrophages.,” Clinical Rheumatology vol. 147, no. 11, pp. 3815–3822, Dec. 1991.
O. Ates, G. Hatemi, V. Hamuryudan, and A. Topal-Sarikaya, “Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients,” Clinical Rheumatology, vol. 27, no. 10, pp. 1243–1248, Apr. 2008.
C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” The Lancet, vol. 395, no. 10223, pp. 497–506, Jan. 2020.
C. R. Triggle et al., “A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic,” Frontiers in Immunology, vol. 12, Feb. 2021.
S. Wang et al., “Cytokine Storm in Domestic Pigs Induced by Infection of Virulent African Swine Fever Virus,” Frontiers in Veterinary Science, vol. 7, Jan. 2021.
W. Yang et al., “Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China,” Journal of Infection, vol. 80, no. 4, Feb. 2020.
X. Yang et al., “Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study,” The Lancet Respiratory Medicine, vol. 8, no. 5, pp. 475–481, Feb. 2020.
D. Wang et al., “Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China,” JAMA, vol. 323, no. 11, pp. 1061–1069, Feb. 2020.
S. Najmeh, J. Marzieh, L. Arash, K. Shahzamani, S. Dashti, and T. Gholamreza, “Association of IL-10 Gene in Protection Against COVID-19 Disease,” Jundishapur Journal of Microbiology, vol. 16, no. 7, Aug. 2023.
S. Preciado, S. Muntión, and Fermín Sánchez-Guijo, “Improving hematopoietic engraftment: Potential role of mesenchymal stromal cell-derived extracellular vesicles,” Stem Cells, vol. 39, no. 1, pp. 26–32, Oct. 2020.
]20] S. K. Dhar, V. K, S. Damodar, S. Gujar, and M. Das, “IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression,” Heliyon, vol. 7, no. 2, p. e06155, Feb. 2021.
E. Sattar, and F. Abolfazl, “Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants,” Human genomics (Print), vol. 17, no. 1, Mar. 2023.
S. Rizvi et al., “Implication of single nucleotide polymorphisms in Interleukin-10 gene (rs1800896 and rs1800872) with severity of COVID-19,” Egyptian Journal of Medical Human Genetics, vol. 23, no. 1, Oct. 2022.
Z. Degaim et al., “Detection of intracellular adhesion (ica) B gene in Staphylococcus aureus isolated from wound infections,” University of Thi-Qar Journal of Medicine, Apr. 2019.
R. de C. C. M. de Brito, N. Lucena-Silva, L. C. Torres, C. F. Luna, J. de B. Correia, and G. A. P. da Silva, “The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia,” BMC Pulmonary Medicine, vol. 16, no. 1, Dec. 2016.
Y. Zhou et al., “Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus, National Science Review Volume 7, Issue 6 Pp. 998–1002” Feb. 2020.
N. Kirtipal and S. Bharadwaj, “Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans,” Journal of Biomolecular Structure and Dynamics, vol. 39, no. 12, pp. 4563–4565, Jun. 2020.
S. Aladawy, L. Adel, S. Abdel Salam, R. Raafat, and M. Khattab, “Polymorphism in promotor region of IL6 gene as a predictor for severity in COVID -19 patients,” Egyptian journal of Immunology, vol. 29, no. 2, pp. 01–09, Apr. 2022.
L. Karcioglu Batur and N. Hekim, “The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate,” Journal of Medical Virology, vol. 93, no. 3, pp. 1409–1413, Aug. 2020.
Z. S. Ulhaq and G. V. Soraya, “Anti-IL-6 Receptor Antibody Treatment for Severe COVID-19 and the Potential Implication of IL-6 Gene Polymorphisms in Novel Coronavirus Pneumonia,” SSRN Electronic Journal, 2020.
A. Naing et al., “Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors,” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 34, no. 29, pp. 3562–3569, Oct. 2016.
Z. Degaim et al., “Detection of clfA Gene in Staphylococcus aureus Isolated From Tonsillitis Patients,” College of Education for Pure Science Journal, vol. 9, no. 1, pp.184189,Mar.2019.
Z.-R. Mao, S.-L. Zhang, and B. Feng, “Association of IL-10 (-819T/C, -592A/C and -1082A/G) and IL-6 -174G/C gene polymorphism and the risk of pneumonia-induced sepsis,” Biomarkers, vol. 22, no. 2, pp. 106–112, Aug. 2016.
N. Vadgama et al., “SARS-CoV-2 Susceptibility and ACE2 Gene Variations Within Diverse Ethnic Backgrounds,” Frontiers in Genetics, vol. 13, Apr. 2022.
A. Vitkauskaite et al., “IL-6 597A/G (rs1800797) and 174G/C (rs1800795) Gene Polymorphisms in the Development of Cervical Cancer in Lithuanian Women,” Medicina, vol. 57, no. 10, p. 1025, Sep. 2021.
H. Han et al., “Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors,” Emerging Microbes & Infections, vol. 9, no. 1, pp. 1123–1130, Jan. 2020.
M. Palivonaite, G. Gedvilaite, B. Glebauskiene, L. Kriauciuniene, V. Rovite, and R. Liutkeviciene, “IL-10 Gene Rs1800871, Rs1800872, and Rs1800896 Polymorphisms and IL-10 Serum Levels Association with Pituitary Adenoma,” Biomedicines, vol. 10, no. 8, p. 1921, Aug. 2022.
T. Men et al., “The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies,” Oncotarget, vol. 8, no. 28, pp. 45994–46005, Apr. 2017.
] B. Diao et al., “Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19),” Frontiers in Immunology, vol. 11, May 2020.
] E. Benetti et al., “ACE2 gene variants may underlie inter individual variability and susceptibility to COVID-19 in the Italian population,” European Journal of Human Genetics, vol. 28, no. 11, pp. 1602–1614, Jul. 2020.
Santos, R. Luiz, J. L. Paz, Maria, K. Valéria, and L. Nepomuceno, “Study of TNF-α, IFN-γ, TGF-β, IL-6, and IL-10 gene polymorphism in individuals from the leprosy endemic area in the Brazilian Amazon,” Meta Gene, vol. 25, pp. 100740–100740, May 2020.
M. Jasim, A. Mater, and D. Zainab Dakhil, “Detection of intracellular adhesion (ica) B gene in Staphylococcus aureus isolated from wound infections,” University of Thi-Qar Journal Of Medicine, vol. 16, no. 2, pp. 185–192, 2018, Accessed: Dec. 05, 2024.
M. Braga et al., “Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis,” Frontiers in Immunology, vol. 12, Jul. 2021.
D. J. Langton et al., “The influence of HLA genotype on the severity of COVID‐19 infection,” HLA, vol. 98, no. 1, pp. 14–22, May 2021.
Downloads
Published
License
Copyright (c) 2025 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
